José Van Der Heyden

Journal Article
A1
open access

Rapid and effective generation of nanobody based CARs using PCR and Gibson Assembly

Stijn De Munter (UGent) , Alexander Van Parys (UGent) , Layla Bral, Joline Ingels (UGent) , Glenn Goetgeluk (UGent) , Sarah Bonte (UGent) , Melissa Pille (UGent) , Lore Billiet (UGent) , Karin Weening (UGent) , Annick Verhee (UGent) , et al.

(2020) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 21(3).

Add to list

Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments

Anje Cauwels (UGent) , Sandra Van Lint (UGent) , Franciane Paul, Genevieve Garcin, Stefaan De Koker (UGent) , Alexander Van Parys (UGent) , Thomas Wüest (UGent) , Sarah Gerlo (UGent) , José Van Der Heyden (UGent) , Yan Bordat, et al.

(2018) CANCER RESEARCH. 78(2). p.463-474

Add to list

Theranostic radiolabeled anti-CD20 sdAb for targeted radionuclide therapy of non-Hodgkin lymphoma

Ahmet Krasniqi, Matthias D'Huyvetter, Catarina Xavier, Kevin Van der Jeught, Serge Muyldermans, José Van Der Heyden (UGent) , Tony Lahoutte, Jan Tavernier (UGent) and Nick Devoogdt

(2017) MOLECULAR CANCER THERAPEUTICS. 16(12). p.2828-2839

Add to list

A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment

Anje Cauwels (UGent) , Sandra Van Lint (UGent) , Geneviève Garcin, Jennyfer Bultinck (UGent) , Franciane Paul, Sarah Gerlo (UGent) , José Van Der Heyden (UGent) , Yann Bordat, Dominiek Catteeuw (UGent) , Lode De Cauwer (UGent) , et al.

(2017) ONCOIMMUNOLOGY. 7(3).

Add to list

Journal Article
A1
open access

TYK2-induced phosphorylation of Y640 suppresses STAT3 transcriptional activity

Raffaele Mori, Joris Wauman (UGent) , Laura Icardi (UGent) , José Van Der Heyden (UGent) , Lode De Cauwer (UGent) , Frank Peelman (UGent) , Karolien De Bosscher (UGent) and Jan Tavernier (UGent)

(2017) SCIENTIFIC REPORTS. 7.

Add to list

Journal Article
A1
open access

MAPPI-DAT : data management and analysis for protein-protein interaction data from the high-throughput MAPPIT cell microarray platform

Surya Gupta (UGent) , Veronic De Puysseleyr, José Van Der Heyden (UGent) , Davy Maddelein (UGent) , Irma Lemmens (UGent) , Sam Lievens (UGent) , Sven Degroeve (UGent) , Jan Tavernier (UGent) and Lennart Martens (UGent)

(2017) BIOINFORMATICS. 33(9). p.1424-1425

Add to list

Proteome-scale binary interactomics in human cells

Sam Lievens (UGent) , José Van Der Heyden (UGent) , Delphine Masschaele (UGent) , Leentje De Ceuninck (UGent) , Ioanna Petta (UGent) , Surya Gupta (UGent) , Veronic De Puysseleyr, Virginie Vauthier (UGent) , Irma Lemmens (UGent) , Dries De Clercq, et al.

(2016) MOLECULAR & CELLULAR PROTEOMICS. 15(12). p.3624-3639

Add to list

Journal Article
A1
open access

Leptin's metabolic and immune functions can be uncoupled at the ligand/receptor interaction level

Lennart Zabeau (UGent) , Cathy J Jensen, Sylvie Seeuws (UGent) , Koen Venken (UGent) , Annick Verhee (UGent) , Dominiek Catteeuw (UGent) , Geert van Loo (UGent) , Hui Chen, Ken Walder, Jacob Hollis, et al.

(2015) CELLULAR AND MOLECULAR LIFE SCIENCES. 72(3). p.629-644

Add to list

High efficiency cell-specific targeting of cytokine activity

Geneviève Garcin, Franciane Paul, Markus Staufenbiel, Yann Bordat, José Van Der Heyden (UGent) , Stephan Wilmes, Guillaume Cartron, Florence Apparailly, Stefaan De Koker (UGent) , Jacob Piehler, et al.

(2014) NATURE COMMUNICATIONS. 5.

Add to list

MAPPIT and Co: the importance of system artifacts

Jan Tavernier (UGent) , Leentje De Ceuninck (UGent) , Sarah Gerlo (UGent) , Irma Lemmens (UGent) , Sam Lievens (UGent) , José Van Der Heyden (UGent) and Joris Wauman (UGent)

(2013) CYTOKINE. 63(3). p.303-304

Academic Bibliography

José Van Der Heyden

Rapid and effective generation of nanobody based CARs using PCR and Gibson Assembly

Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments

Theranostic radiolabeled anti-CD20 sdAb for targeted radionuclide therapy of non-Hodgkin lymphoma

A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment

TYK2-induced phosphorylation of Y640 suppresses STAT3 transcriptional activity

MAPPI-DAT : data management and analysis for protein-protein interaction data from the high-throughput MAPPIT cell microarray platform

Proteome-scale binary interactomics in human cells

Leptin's metabolic and immune functions can be uncoupled at the ligand/receptor interaction level

High efficiency cell-specific targeting of cytokine activity

MAPPIT and Co: the importance of system artifacts

Contents

Support

Contact